Diabetes treatment is constantly evolving, with new therapeutic options emerging to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the actions of naturally occurring hormones involved in bloodglucose regulation. These novel agents demonstrate substantial efficacy in im

The management of diabetes is with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant traction. These medications offer promising mechanisms for controlling blood sugar levels and could improve the lives of individuals living with diabetes. Reta| acts by slowin